Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
MBX Biosciences’ $187.7 Million IPO
Neo Medical SA’s Series B and $68 Million Equity Investment
Wilson Sonsini Goodrich & Rosati advised Neo Medical on U.S. aspects of the financing. Neo Medical SA (Neo), a Swiss technology company specializing in spine surgery,...
MBX Biosciences’ $63.5 Million Series C Financing Round
Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on patent matters on the transaction. MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, announced a $63.5 million Series...